CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • #Immune2Cancer Day Ignites Support for CRI

    The cornerstone of Cancer Immunotherapy MonthTM is #Immune2Cancer Day, June 14, a day dedicated to showcasing the…
    June 14, 2024| CRI Staff
  • CRI Associate Board Pours Out Hope at UnWINEd 

    On Thursday, June 13, 2024, the Cancer Research Institute (CRI) Associate Board hosted an unforgettable evening at…
    June 14, 2024| CRI Staff
  • Acute Lymphoblastic Leukemia Survivor Kristin Kleinhofer Takes Over CRI’s Instagram

    Patient advocate and leukemia survivor Kristin shares a day in her life on Instagram. 

    June 22, 2021| Gabriella Rojas
  • Immunotherapy: Oswald’s Partner in the Fight

    In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy…

    November 24, 2020| Caroline Offit
  • Karen’s Immunotherapy Story: Empowerment Through Education

    CRI ImmunoAdvocate and breast cancer avenger, Karen Peterson, discusses enrolling in an immunotherapy clinical trial, self-advocacy, and…

    October 1, 2020| Caroline Offit
  • Melanoma and Immunotherapy: Tara’s Journey to Become a Cancer Patient Advocate

    Melanoma veteran Tara Ryan shares her experience with taking control of her health, resilience in the face…

    May 4, 2020| Caroline Offit
  • Isolde Arzt’s Immunotherapy Story: Raising Awareness of Melanoma in Mexico

    Melanoma survivor Isolde Arzt shares her path from cancer patient to patient advocate in Mexico.

    March 18, 2020| Sofia Balog
  • Gordon Levine’s Immunotherapy Experience: A New Understanding of Advocacy

    Colorectal cancer veteran Gordon Levine discusses genomic testing, clinical trials, patient advocacy, and access to immunotherapy. 

    November 16, 2019| Sofia Balog
  • Transforming Experience into Advocacy

    Judy Perkins discusses her experience receiving immunotherapy for metastatic stage 4 breast cancer and insights she shared…

    March 26, 2019| Caroline Offit

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute